News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kythera Biopharmaceuticals (KYTH) Appoints F. Michael Ball to Board of Directors


9/20/2013 10:00:44 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CALABASAS, Calif., Sept. 19, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it has named F. Michael (Mike) Ball, Chief Executive Officer (CEO) of Hospira, Inc. (NYSE:HSP) to its Board of Directors.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES